Acute Pain

The updated software will begin being implemented this month for use with the Prometra Pump System.

Heart patients discharged from the hospital with an opioid prescription were less likely to participate in planned follow-up care than those without prescribed opioids.

Crizanlizumab is being developed to prevent painful and unpredictable vaso-occlusive crises in patients with sickle cell disease.

The FDA has approved 2 new dosages of the pain reliever that combines benzhydrocodone and acetaminophen.

New research finds patients face a higher risk of pneumonia if they are taking opioids. The danger is even more pronounced for patients living with HIV.

The guidance touches on hand hygiene, airway management, environmental disinfection, and IV drug injection recommendations.

The US Department of Health and Human Services updated guidelines feature key recommendations for young children aged 3-5, youths aged 6-17, adults, older adults, pregnant and post-partum women, as well as adults with chronic health conditions and disabilities.

Ronald Gentile, MD, and colleagues investigated pain-reduction strategies following intravitreal injections. The results have implications for patient experience, physician ratings, and treatment adherence.

A meta-analysis shows the experimental therapy has favorable benefits for certain aspects of pain, as well as preferrable avenues of administration.

A small study found that ketamine decreased symptoms of depression—investigators studied its effects in combination with the opioid-blocker naltrexone compared to a placebo.

The director of Pain Management and Palliative Care at the Englewood Hospital & Medical Center in Englewood, NJ, explains how analgesics may come to the forefront of pain management care.

How issues with pain in patients with Lyme disease or opioid-induced constipation can be managed in a timely, efficient manner.

The SPRINT endura and extensa are cleared for both chronic and acute pain including post-operative pain and post-traumatic pain.

The FDA accepted the NDA for NKTR-181, a drug with slowed entry into the brain that attenuates the dopamine release underlying euphoria.

Researchers identified 6 types of potentially inappropriate prescriptions, all of which were associated with higher hazards for all-cause mortality, 4 with non-fatal overdose, and 5 with fatal overdose.

The wearable device, Drug Relief, is a non-narcotic option for treatment and eases withdrawal symptoms within just 30-60 minutes.

The oral treatment was safe and efficacious over the course of a 12-week treatment period.

Several studies point to the links between prenatal exposure to painkillers and increased risks for ADHD and autism symptoms.

Despite the challenges of studying the condition, researchers showed that galcanezumab significantly reduced weekly cluster headache attacks compared to placebo.

Researchers found that biased language affected a physician’s attitude toward a patient as well as the aggressiveness of their pain management choices.

Patients who had previously failed ≥2 preventative migraine treatments were effectively treated with galcanezumab, especially when compared to placebo.

Trial results on the recently FDA-approved gammaCore device will be presented at the American Academy of Neurology (AAN) annual meeting.

If approved, NTX-011 may help combat the nationwide opioid epidemic.

Apadaz is the first prodrug of hydrocodone and acetaminophen to be FDA approved.

NSAIDs may help a variety of painful conditions, but come with heart risks.

There are many challenges that confront pain specialists on a daily basis. Despite those challenges, seeing their patients recover and live a better quality of life is reward enough to keep them optimistic for the future of the field.

Injectable medications are being used for everything from chronic pain to cancer related pain. While doctors are working to help their patients manage their symptoms they are also keeping a close eye on potential abuse and illegal activity with the medication.

Ketamine is not a new tool in the arsenal of pain medication but doctors are finding new ways to use it in order to provide relief for patients. As an infusion ketamine is being used to treat chronic pain syndromes.

In an effort to avoid prescribing opioids except in cases where they are needed doctors are finding new ways to provide relief for their patients. This can include newly developed implantable medications which can help reduce pain and increase quality of life.

When opioids first hit the market they were specifically promoted for their non-addictive traits. Over the past few decades that has been disproven as doctors look for the best way to treat patients and avoid the risk of unwanted addiction and other issues.